Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paras Famta

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Drug Development and Industrial Pharmacy|May 22, 2025
Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticlesNaitik Jain, Syed Shahrukh, Paras Famta, et al.
Drug Delivery and Translational Research|October 31, 2023
Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variabilitySaurabh Shah, Paras Famta, Ganesh Vambhurkar, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|November 21, 2022
Instigation of the epoch of nanovaccines in cancer immunotherapySaurabh Shah, Paras Famta, Vinod Tiwari, et al.
Life Sciences|August 15, 2023
Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancerVivek Phatale, Paras Famta, Dadi A Srinivasarao, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 19, 2023
Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemiaParas Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
Drug Delivery and Translational Research|July 22, 2024
Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapyDadi A Srinivasarao, Saurabh Shah, Paras Famta, et al.
Cancer Pathogenesis and Therapy|January 28, 2025
Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting <i>de novo</i> restorative regimensParas Famta, Saurabh Shah, Biswajit Dey, et al.
Molecular Pharmaceutics|September 15, 2022
Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer TherapySaurabh Shah, Paras Famta, Deepkumar Bagasariya, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Metal-organic frameworks as therapeutic chameleons: revolutionizing the cancer therapy employing novel nanoarchitectonicsSajja Bhanu Prasad, Akshay Shinde, Dadi A Srinivasrao, et al.
Drug Delivery and Translational Research|July 15, 2024
Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeationParas Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Drug Development and Industrial Pharmacy|May 22, 2025
Combating breast cancer-associated metastasis using paclitaxel and tranilast-loaded human serum albumin nanoparticlesNaitik Jain, Syed Shahrukh, Paras Famta, et al.
Drug Delivery and Translational Research|October 31, 2023
Sulfo-butyl ether β-cyclodextrin inclusion complexes of bosutinib: in silico, in vitro and in vivo evaluation in attenuating the fast-fed variabilitySaurabh Shah, Paras Famta, Ganesh Vambhurkar, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|November 21, 2022
Instigation of the epoch of nanovaccines in cancer immunotherapySaurabh Shah, Paras Famta, Vinod Tiwari, et al.
Life Sciences|August 15, 2023
Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancerVivek Phatale, Paras Famta, Dadi A Srinivasarao, et al.
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|July 19, 2023
Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemiaParas Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
Drug Delivery and Translational Research|July 22, 2024
Unravelling the role of tumor microenvironment responsive nanobiomaterials in spatiotemporal controlled drug delivery for lung cancer therapyDadi A Srinivasarao, Saurabh Shah, Paras Famta, et al.
Cancer Pathogenesis and Therapy|January 28, 2025
Despicable role of epithelial-mesenchymal transition in breast cancer metastasis: Exhibiting <i>de novo</i> restorative regimensParas Famta, Saurabh Shah, Biswajit Dey, et al.
Molecular Pharmaceutics|September 15, 2022
Tuning Mesoporous Silica Nanoparticles in Novel Avenues of Cancer TherapySaurabh Shah, Paras Famta, Deepkumar Bagasariya, et al.
Asian Journal of Pharmaceutical Sciences|March 11, 2026
Metal-organic frameworks as therapeutic chameleons: revolutionizing the cancer therapy employing novel nanoarchitectonicsSajja Bhanu Prasad, Akshay Shinde, Dadi A Srinivasrao, et al.
Drug Delivery and Translational Research|July 15, 2024
Amelioration of breast cancer therapies through normalization of tumor vessels and microenvironment: paradigm shift to improve drug perfusion and nanocarrier permeationParas Famta, Saurabh Shah, Ganesh Vambhurkar, et al.
Pageof 5